| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/13/2009 | CN101428030A Compound dipyridamole/acetophen sustained-release capsule and preparation thereof |
| 05/13/2009 | CN101428013A Uses of tanshinone IIA vein emulsion in treating brain diseases |
| 05/13/2009 | CN101428012A Medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 05/13/2009 | CN101427993A Prostaglandin microemulsion gel rubber preparation and method of producing the same |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/13/2009 | CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 05/13/2009 | CN100486971C Compound 2,3,4,6,8-pentamethoxyl-dibenzofuran and its use |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/13/2009 | CN100486646C Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy |
| 05/13/2009 | CN100486637C Composition of external remedy for treating hemorrhoids, and preparation method |
| 05/13/2009 | CN100486625C Health wine and its preparation process |
| 05/13/2009 | CN100486615C Chinese traditional medicine preparation for treating coronary heart disease and angina pectoris and preparation method thereof |
| 05/13/2009 | CN100486604C Chinese medicine extract formulation for treating heart incompetence and its process |
| 05/13/2009 | CN100486597C A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof |
| 05/13/2009 | CN100486584C Application of amygdalin in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 05/13/2009 | CN100486578C Medicine composition and its application in preparation of medicine for treating or preventing cardiovascular and cerebrovascular diseases |
| 05/13/2009 | CN100486577C Nimodipine lipid nano particle compositions, and its preparation method |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486574C Remedies and/or preventives for nervous system disorders |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486570C Use of luciferin and derivatives in preparing medicine for treating live animal secretory diarrhea and inhibiting cyst growth |
| 05/13/2009 | CN100486566C New type quick oral disintegration tablet of Subing and preparation method |
| 05/13/2009 | CN100486562C Medicine composition for treating coronary heart disease and its preparation process and use |
| 05/13/2009 | CN100486561C Manufacturing technique of freeze-dried wilsonii powder for injection |
| 05/13/2009 | CN100486464C Preparation method of sweet potato health beverage |
| 05/12/2009 | US7531663 treatment or prophylaxis of cardiovascular disease, metabolic disease, cancerous disease, or fibrotic disease; arrhythmias, life-threatening cardiac ventricular fibrillation, myocardial infarction, angina pectoris; ischemic states of the heart, diabetes |
| 05/12/2009 | US7531633 Immunotherapy against infection; harvesting antibodies directed against Staphylococcus from blood of immunized subject for use as immunotherapeutic agents |
| 05/12/2009 | US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders |
| 05/12/2009 | US7531576 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531511 Injecting fibroblast growth factor-2 directly into the myocardium |
| 05/12/2009 | US7531510 Methods of recruiting fibroblasts by administering G-CSF |
| 05/12/2009 | US7531501 Method of treating endothelial injury |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
| 05/12/2009 | CA2546987C 5,7-diaminopyrazolo [4,3-d] pyrimidines with pde-5 inhibiting activity |
| 05/12/2009 | CA2478237C Use of adapalene for the treatment of dermatological disorders |
| 05/12/2009 | CA2389156C Benzamidine derivatives |
| 05/12/2009 | CA2386404C Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 05/12/2009 | CA2377301C Controlled release and taste masking oral pharmaceutical compositions |
| 05/12/2009 | CA2361402C Bis-sulfonamides |
| 05/12/2009 | CA2348890C Use of staurosporine derivatives for treating ocular neovascular diseases |
| 05/12/2009 | CA2341973C Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid |
| 05/12/2009 | CA2303448C Specific steady-state r-type ca2+ channel blockers and use thereof |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/12/2009 | CA2253997C Phosphonic acid-substituted benzazepinone-n-acetic acid derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| 05/07/2009 | WO2009059048A2 (+)-opioids and methods of use |
| 05/07/2009 | WO2009059032A2 Uses and isolation of very small embryonic-like (vsel) stem cells |
| 05/07/2009 | WO2009058400A1 Compositions for tissue repair/regeneration |
| 05/07/2009 | WO2009057733A1 Novel indole derivative having anti-angiogenic activity |
| 05/07/2009 | WO2009057725A1 Protease-treated jew's mallow extract composition, method for production of the composition, and anti-hypertensive agent or beverage/food comprising the composition |
| 05/07/2009 | WO2009057724A1 Jew's mallow-derived synthetic-resin-adsorbed fraction composition having vasodepressing activity, vasodepressing agent or food/beverage comprising the adsorbed fraction composition, and method for producing the adsorbed fraction composition |
| 05/07/2009 | WO2009057604A1 Agent for promoting the secretion of adiponectin and/or inhibiting the decrease in the secretion of adiponectin |
| 05/07/2009 | WO2009057569A1 Film-coated preparation |
| 05/07/2009 | WO2009057313A1 Method for induction of proliferation/differentiation of endothelial progenitor cell (epc) |
| 05/07/2009 | WO2009056952A1 Geminal bisphosphonates, their preparation and their use in the field of oncology |
| 05/07/2009 | WO2009056826A1 Diagnostic and therapeutic methods and compositions for cardiovascular disease |
| 05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | WO2009056651A1 Angiotensin-carrier formulation |
| 05/07/2009 | WO2009056070A1 Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application |
| 05/07/2009 | WO2009055935A1 Hyperbranched polyglycerol for improving heart function |
| 05/07/2009 | WO2009055854A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | WO2009037707A3 N-phenyl anthranilic acid derivatives and uses thereof |
| 05/07/2009 | WO2009033745A3 Use of a peptide as a therapeutic agent |
| 05/07/2009 | WO2009024287A3 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 05/07/2009 | WO2008156828A3 Renin inhibitors |
| 05/07/2009 | WO2008127682A3 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor |
| 05/07/2009 | WO2008077555A3 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
| 05/07/2009 | US20090118361 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 05/07/2009 | US20090118359 Food product |
| 05/07/2009 | US20090118351 Angiotensin I-Converting Enzyme (ACE) Inhibitors |
| 05/07/2009 | US20090118345 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 05/07/2009 | US20090118342 Design and synthesis of biotinylated probes for n-acyl-ethanolamines |
| 05/07/2009 | US20090118334 Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin ii receptor blocker |
| 05/07/2009 | US20090118329 Novel Substituted 2-Amino-4-Phenyldihydroquinolines, Processes for their Preparation, Pharmaceutical Compositions and Methods for Their Use |
| 05/07/2009 | US20090118324 Mapk/erk kinase inhibitors |
| 05/07/2009 | US20090118319 Fused and Spirocycle Compounds and the Use Thereof |
| 05/07/2009 | US20090118317 Statin-Carboxyalkylether Combinations |
| 05/07/2009 | US20090118313 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase |
| 05/07/2009 | US20090118302 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118293 Methods for reducing hospitalizations related to heart failure |
| 05/07/2009 | US20090118287 Organic compounds |
| 05/07/2009 | US20090118283 Amide Derivatives as Kinase Inhibitors |
| 05/07/2009 | US20090118281 Amino Alcohol Derivatives And Their Use As Renin Inhibitor |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118266 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 05/07/2009 | US20090118265 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 05/07/2009 | US20090118264 Medicament having neovascularization promoting action |
| 05/07/2009 | US20090118258 Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists |
| 05/07/2009 | US20090118256 Chronotherapeutic diltiazem formulations and the administration thereof |